MarketInOut Stock Screener Log In | Sign Up
 

Profound Medical Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 10/08/2026 16:00
Profound Medical Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization242.58 mln
Float35.42 mln
Earnings Date10/29/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-1.17
Manipulation likely

Relative Strength

95 / 100
Top performer

Debt / Equity

0.15
Very low leverage

Pre-Tax Margin

-170%
Severely loss-making

ROE

-65.99
Deeply negative

Business Description

Profound Medical Corp. is a Canadian medical technology company based in Mississauga that sells two non-surgical treatment systems used in hospitals across Canada, the United States, Germany, China, and Finland. Its main product, TULSA-PRO, uses MRI imaging and sound wave energy to destroy prostate tissue without making a single cut, guided in real time by temperature monitoring. The company's second system, Sonalleve, applies the same approach to treat conditions such as uterine fibroids, bone pain from cancer spread, and certain benign tumors.

Key Fundamentals

EPS-0.99
ROE-65.99
RPS0.57
ROIC-121
ROA-44.31
EBITDA, mln-32.03
EV / EBITDA-5.59
EV / EBIT-5.51
Revenue, mln19.09
EV / Revenue9.38

Quote Details

Last 6.91
Change 1.23 (21.65%)
Open 6.50
Volume 2,950,023
Turnover 20,384,658
Average Volume 277,212

Financial Ratios

Pre-Tax Profit Margin-170
Leverage Ratio1.25
Current Ratio6.46
Price / Book4.26
Price / Tangible Book4.26
Debt / Equity0.15
Price / Sales10.13

Financial Strength

Altman Z-Score3.08
Piotroski F-Score 4 / 9
Beneish M-Score-1.17
Short Ratio12.91
Short % of Float4.87

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 18.12% 95 / 100   
1 Month 1.62% 79 / 100   
2 Months 1.47% 64 / 100   
6 Months 7.3% 67 / 100   
1 Year 6.97% 57 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us